Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-021820

President, R&D sold 622 shares at $29.87 ($18,579)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bergstrom Donald A President, R&D 2022-03-29 Sale −622 $29.87 $18,579 94,304 D: show line 1 in the form
Open-market sales · 622 sh · avg $29.87 · $18,579
Loading xslF345X03/doc4.xml…